CAV3 and familial dilated cardiomyopathy: Additionally, CAV3 overexpression alleviates DCM by maintaining NDUFA10 stability, reducing degradation through the lysosomal pathway, improving mitochondrial function, reducing ROS production, and decreasing cardiomyocyte apoptosis.